Abstract
Imaging plays an important role in the assessment of prostate cancer including detection, characterisation, localisation and guidance of biopsy, treatment planning, treatment response assessment and surveillance. Radiological techniques complementing clinical assessment in current practice include transrectal ultrasound (TRUS), multi-parametric magnetic resonance imaging (MRI) for locoregional disease and contrast-enhanced computed tomography (CT) for systemic disease. Whole-body MRI is also an emerging technique for metastatic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NICE clinical guidelines. Prostate cancer. 2014. http://publications.nice.org.uk/prostate-cancer-diagnosis-and-treatment-cg175. Accessed 8/7/2014.
Pondman KM, Fütterer JJ, ten Haken B, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol. 2008;54(3):517–27.
Yacoub JH, Verma S, Moulton JS, Eggener S, Aytekin O. Imaging-guided prostate biopsy: conventional and emerging techniques. Radiographics. 2012;32(3):819–37.
Poon PY, McCallum RW, Henkelman MM, et al. Magnetic resonance imaging of the prostate. Radiology. 1985;154(1):143–9.
Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–57.
Rouviere O, Hartman RP, Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol. 2006;16(2):276–84.
Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal—pelvic phased-array coils. Radiology. 1994;193(3):703–9.
Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology. 2010;255(1):89–99.
Delongchamps NB, Rouanne M, Flam T, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int. 2011;107(9):1411–8.
Umbehr M, Bachmann LM, Held U, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol. 2009;55(3):575–90.
Donati OF, Afaq A, Vargas HA, et al. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor gleason score. Clin Cancer Res. 2014;20(14):3705–11. [Epub ahead of print].
Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: staging by clinical assessment, CT and MR imaging. Radiology. 1987;162(2):331–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Goh, V., Rottenberg, G. (2017). Prostate Cancer: Radiological Imaging. In: Cook, G. (eds) PET/CT in Prostate Cancer. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-57624-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-57624-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57623-7
Online ISBN: 978-3-319-57624-4
eBook Packages: MedicineMedicine (R0)